Literature DB >> 16501775

Prolonged survival and immune reconstitution after chagasic meningoencephalitis in a patient with acquired immunodeficiency syndrome.

Marcelo Corti1, Claudio Yampolsky.   

Abstract

We report a case of cerebral meningoencephalitis due to Trypanosoma cruzi in a patient with acquired immunodeficiency syndrome. The patient presented with seizures and focal neurological signs. Definitive diagnosis of chagasic meningoencephalitis was made by demonstration of free trypomastigote forms in the cerebrospinal fluid. Benznidazol was prescribed with clinical and neurological improvement. Antiretroviral drugs improved cellular immunity and three years later the patient presents a good clinical condition with immune reconstitution and undetectable viral load. Chagasic meningoencephalitis has a poor prognosis when specific treatment is not initiated or is delayed. A high index of diagnosis is necessary for early diagnosis and treatment, especially in endemic areas for Trypanosoma cruzi infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16501775     DOI: 10.1590/s0037-86822006000100018

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  8 in total

1.  A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection.

Authors:  Patricia S Doyle; Yuan M Zhou; Juan C Engel; James H McKerrow
Journal:  Antimicrob Agents Chemother       Date:  2007-08-13       Impact factor: 5.191

2.  CHAGASIC MENINGOENCEPHALITIS IN AN HIV INFECTED PATIENT WITH MODERATE IMMUNOSUPPRESSION: PROLONGED SURVIVAL AND CHALLENGES IN THE HAART ERA.

Authors:  Renata Buccheri; Maria José Kassab; Vera Lucia Teixeira de Freitas; Sheila Cristina Vicente da Silva; Rita C Bezerra; Zarifa Khoury; Maria Aparecida Shikanai-Yasuda; José E Vidal
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015-12       Impact factor: 1.846

Review 3.  Parasitic infections in HIV infected individuals: diagnostic & therapeutic challenges.

Authors:  Veeranoot Nissapatorn; Nongyao Sawangjaroen
Journal:  Indian J Med Res       Date:  2011-12       Impact factor: 2.375

4.  In vitro Leishmanicidal and Trypanosomicidal Properties of Imidazole-Containing Azine and Benzoazine Derivatives.

Authors:  Álvaro Martín-Montes; Kristina Kolodová; Clotilde Marín; María José Rosales-Lombardo; Manuel Sánchez-Moreno; Lucía de Andrés-Gordo; Carmen Cano; Lucrecia Campayo; Alberto Gómez-Muñoz; Ana M Sanz; María J R Yunta
Journal:  ChemMedChem       Date:  2021-10-19       Impact factor: 3.540

5.  Use of a Chagas Urine Nanoparticle Test (Chunap) to Correlate with Parasitemia Levels in T. cruzi/HIV Co-infected Patients.

Authors:  Yagahira E Castro-Sesquen; Robert H Gilman; Carolina Mejia; Daniel E Clark; Jeong Choi; Melissa J Reimer-McAtee; Rosario Castro; Edward Valencia-Ayala; Jorge Flores; Natalie Bowman; Ricardo Castillo-Neyra; Faustino Torrico; Lance Liotta; Caryn Bern; Alessandra Luchini
Journal:  PLoS Negl Trop Dis       Date:  2016-02-26

Review 6.  Fever of unknown origin due to zoonoses.

Authors:  Dennis J Cleri; Anthony J Ricketti; John R Vernaleo
Journal:  Infect Dis Clin North Am       Date:  2007-12       Impact factor: 5.982

7.  Repositioning drug strategy against Trypanosoma cruzi: lessons learned from HIV aspartyl peptidase inhibitors.

Authors:  Leandro Stefano Sangenito; Claudia Masini d'Avila-Levy; Marta Helena Branquinha; André Luis Souza Dos Santos
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-03-16       Impact factor: 2.743

Review 8.  Acute chagas disease: new global challenges for an old neglected disease.

Authors:  Daniela V Andrade; Kenneth J Gollob; Walderez O Dutra
Journal:  PLoS Negl Trop Dis       Date:  2014-07-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.